News
Integrative data-intensive research for better drug design
The 23rd EuroQSAR Symposium in Heidelberg, Germany will focus on “Integrative Data-Intensive Approaches to Drug Design” and be attended by about 300 …
Multiscale simulations unveil molecular mechanisms that shape brain plasticity
New publication on multiscale molecular simulations to investigate adenylyl cyclase-based signaling in the brain, together with colleagues collaborating in the Human …
Integrative data-intensive approaches to drug design
The 23rd EuroQSAR Symposium will take place in Heidelberg, chaired by HITS group leader Rebecca Wade. Deadline for abstract submission: 4 August 2022 …
“The magic triangle” advances molecular research with machine learning and simulations
The “SIMPLAIX” collaboration started with an inaugural symposium in Heidelberg. Researchers from HITS, Heidelberg University, and Karlsruhe Institute of Technology (…
Computer simulations and Artificial Intelligence – a “booster” for molecular research
In the new “SIMPLAIX” collaboration, researchers from HITS, Heidelberg University, and Karlsruhe Institute of Technology (KIT) are addressing challenges in the …
Registration open: Training Workshop on Tools for Molecular Simulation of Neuronal Signaling Cascades
The HBP training workshop on Tools for Molecular Simulation of Neuronal Signaling Cascades will take place online on 7-10 March 2022 (free …
Computing drug-target binding kinetics: three papers in the Journal of Chemical Theory and Computation
How long does a drug molecule stay bound to its protein target? How quickly does it bind to and dissociate from …
Searching for a way out of the brain fog caused by COVID-19
HITS is a partner in the new EU-funded research program “BRAVE” that proposes tackling COVID-19 brain inflammation with computer-designed molecules. The …
powered by Borlabs Cookie